Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2018, Article ID 1890978, 7 pages
https://doi.org/10.1155/2018/1890978
Review Article

The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus

Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin, China

Correspondence should be addressed to Zhuo Li; ac.oohay@ouhz_elbon and Guixia Wang; nc.ude.ulj@861gnawg

Received 26 October 2017; Revised 16 February 2018; Accepted 18 March 2018; Published 7 May 2018

Academic Editor: Peter Bolli

Copyright © 2018 You Lv et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [5 citations]

The following is the list of published articles that have cited the current article.

  • Rabi Yacoub, Girish N Nadkarni, Daniel I McSkimming, Lee D Chaves, Sham Abyad, Mark A Bryniarski, Amanda M Honan, Shruthi A Thomas, Madan Gowda, John C He, and Jaime Uribarri, “Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study,” Experimental Biology and Medicine, pp. 153537021881817, 2018. View at Publisher · View at Google Scholar
  • Tatiana Yu Demidova, “Vildagliptin: Ten years in the service for type 2 diabetes mellitus patients. The journey of discovery, innovation and success in clinical practice,” Problemy Endokrinologii, vol. 64, no. 5, pp. 336–347, 2018. View at Publisher · View at Google Scholar
  • Elena V. Pokrovskaya, Minara S. Shamkhalova, and Marina V. Shestakova, “The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2,” Diabetes mellitus, vol. 22, no. 3, pp. 253–262, 2019. View at Publisher · View at Google Scholar
  • Ming Zhong, Yilong Wu, Weijie Ou, Linjing Huang, and Liyong Yang, “Identification of key genes involved in type 2 diabetic islet dysfunction: a bioinformatics study,” Bioscience Reports, vol. 39, no. 5, pp. BSR20182172, 2019. View at Publisher · View at Google Scholar
  • Mark A Bryniarski, Fares Hamarneh, and Rabi Yacoub, “The role of chronic kidney disease-associated dysbiosis in cardiovascular disease,” Experimental Biology and Medicine, pp. 153537021982652, 2019. View at Publisher · View at Google Scholar